Adenine phosphoribosyltransferase (APRT) is a purine salvage enzyme that converts adenine and PRPP into AMP. In Biological Chemistry II, it shows how cells recycle bases instead of building every nucleotide from scratch.
Adenine phosphoribosyltransferase, usually shortened to APRT, is the enzyme that turns adenine into adenosine monophosphate (AMP) by using 5-phosphoribosyl-1-pyrophosphate (PRPP) as the ribose-phosphate donor. The reaction is adenine + PRPP -> AMP + pyrophosphate, and it is one of the cleaner examples of nucleotide salvage in Biological Chemistry II.
If you are looking at the pathway, APRT sits on the salvage side of purine metabolism. Instead of breaking adenine all the way down and starting over, the cell attaches adenine to the activated sugar-phosphate backbone already carried by PRPP. That saves energy and keeps free adenine from building up when nucleotides are being turned over.
The chemistry makes more sense when you think about PRPP as a ready-to-use activated scaffold. APRT does not build the purine ring, and it does not make the adenine base. Its job is to transfer the phosphoribosyl group so the cell can lock adenine back into a nucleotide form. The pyrophosphate that leaves helps drive the reaction forward.
This step matters most in tissues with active nucleotide turnover, where recycled bases can be re-used quickly. Liver and brain are classic examples because they handle constant metabolic activity and need a steady nucleotide supply. If APRT activity drops, adenine can accumulate and get pushed into less desirable breakdown products, which is why this enzyme comes up in disease discussions too.
A common way to miss APRT on a problem set is to confuse salvage with de novo synthesis. De novo purine synthesis builds the purine ring step by step from smaller pieces, while APRT works later, after adenine already exists. So when you see APRT, think recycle, not rebuild.
APRT shows up any time a Biological Chemistry II problem asks how cells maintain nucleotide balance without wasting energy. It connects enzyme kinetics, substrate availability, and pathway regulation in one small reaction, so it is a good checkpoint for whether you can follow a metabolic map instead of memorizing isolated enzymes.
It also gives you a concrete example of why salvage pathways matter. Cells are always breaking down and reusing nucleotides, and APRT helps convert a free base back into AMP, which can then feed RNA synthesis, energy metabolism, or further nucleotide interconversion. That makes APRT part of the cell’s economy: less waste, more reuse.
The enzyme is especially useful for connecting normal metabolism to disease. When APRT is deficient, adenine is not recycled efficiently, and that can contribute to kidney stone problems because the excess base is diverted into harmful byproducts. In class, that kind of link often appears in case questions, pathway diagrams, or short-answer prompts that ask you to explain what happens when a salvage step fails.
Keep studying Biological Chemistry II Unit 5
Visual cheatsheet
view galleryPurine Salvage Pathway
APRT is one of the enzymes that belongs to the purine salvage pathway. That pathway recycles free purine bases instead of forcing the cell to build new nucleotides from scratch. If you can place APRT inside salvage, you can better explain why cells conserve energy and how defects in recycling can change nucleotide levels.
5-Phosphoribosyl-1-pyrophosphate (PRPP)
PRPP is the activated ribose donor APRT uses to make AMP. In pathway questions, PRPP is often the other half of the reaction, so knowing its role helps you read the enzyme step correctly. It also shows up in other purine reactions, which makes it a useful marker for where nucleotide synthesis and salvage intersect.
Adenosine Monophosphate (AMP)
AMP is the product APRT makes from adenine. That matters because AMP is not just a storage form of adenine, it is also a nucleotide that can move into RNA synthesis or be converted into other adenine nucleotides. When you trace APRT, you are following how a base becomes part of the cell’s usable nucleotide pool.
gout
Gout is related to purine breakdown, so it often comes up near APRT in metabolism units. APRT itself does not make uric acid, but it sits in the larger network that controls how much purine material gets recycled versus degraded. That makes it useful for comparing salvage problems with downstream catabolic problems.
A quiz item or pathway question may give you adenine, PRPP, and a salvage enzyme, then ask for the product, the reaction type, or what happens if the enzyme is missing. You should be able to trace the direction of the reaction, name AMP as the product, and explain that APRT recycles a base instead of building a purine ring de novo.
In a case study, you might be asked why adenine buildup could matter in the kidney or how a salvage defect changes nucleotide balance. In a diagram label, look for APRT wherever a free purine base is being reattached to PRPP. If the prompt compares pathways, the clean contrast is salvage versus de novo synthesis.
Adenine phosphoribosyltransferase (APRT) converts adenine plus PRPP into AMP and pyrophosphate.
APRT is a salvage enzyme, so it recycles an existing base instead of building the purine ring from scratch.
The reaction helps conserve energy and maintain the cell’s nucleotide pool, especially in tissues with high turnover.
Low APRT activity can let adenine accumulate and is associated with kidney stone problems.
When you see APRT in a pathway, think about where adenine is being reused, not where purines are first synthesized.
APRT is the enzyme that salvages adenine by transferring a phosphoribosyl group from PRPP to make AMP. In this course, it is a standard example of how cells recycle purines instead of making every nucleotide de novo.
APRT catalyzes adenine + PRPP -> AMP + pyrophosphate. The reaction turns a free base into a nucleotide, which is why it belongs to the purine salvage pathway.
APRT works on an already-made base, while de novo purine synthesis builds the purine ring step by step. If you mix them up, the easiest fix is to remember that salvage recycles and de novo constructs.
If APRT does not work well, adenine is not recycled efficiently and can accumulate. That can lead to harmful downstream products and is linked to kidney stone formation in the context of purine metabolism.